UBS Group Downgrades Afya (NASDAQ:AFYA) to Neutral

Afya (NASDAQ:AFYA) was downgraded by UBS Group from a “buy” rating to a “neutral” rating in a research report issued on Friday, Marketbeat.com reports. They presently have a $16.00 target price on the stock. UBS Group’s price objective points to a potential upside of 14.86% from the stock’s previous close.

AFYA has been the topic of several other reports. Zacks Research lowered Afya from a “hold” rating to a “strong sell” rating in a research note on Friday, January 9th. Wall Street Zen upgraded shares of Afya from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 10th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $22.00 price target (down from $24.50) on shares of Afya in a report on Wednesday, January 7th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. Finally, Sanford C. Bernstein raised shares of Afya to a “market perform” rating in a research report on Friday. One investment analyst has rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $17.38.

Afya Stock Down 3.2%

Shares of NASDAQ:AFYA opened at $13.93 on Friday. Afya has a 1 year low of $13.12 and a 1 year high of $19.90. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.98 and a quick ratio of 0.98. The business’s 50-day moving average is $14.78 and its 200-day moving average is $15.02. The company has a market capitalization of $1.31 billion, a price-to-earnings ratio of 10.02, a P/E/G ratio of 0.52 and a beta of 0.53.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in AFYA. Militia Capital Partners LP acquired a new stake in shares of Afya in the 2nd quarter worth about $71,000. Quantbot Technologies LP bought a new stake in Afya during the 2nd quarter worth approximately $117,000. Van ECK Associates Corp raised its stake in shares of Afya by 15.7% in the third quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock worth $159,000 after purchasing an additional 1,377 shares during the last quarter. State of Wyoming bought a new position in shares of Afya in the second quarter valued at approximately $164,000. Finally, Quadrature Capital Ltd bought a new position in shares of Afya in the second quarter valued at approximately $181,000. 88.02% of the stock is currently owned by institutional investors and hedge funds.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.